Pretreatment with resveratrol, an agonist of SIRT1, almost restored the expression of SIRT1, increased the epigenetic regulation of MeCP2 and CREB, promoted the expression of BDNF, and consequently mitigated the cognitive deficits. The gene discussed is CREB1; the disease is Cognitive impairment.